Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

BACKGROUND: Thymidine analogue resistance mutations (TAMs) selected under treatment with nucleoside analogues generate two distinct genotypic profiles in the HIV-1 reverse transcriptase (RT): (i) TAM1: M41L, L210W and T215Y, and (ii) TAM2: D67N, K70R and K219E/Q, and sometimes T215F. Secondary mutat...

Descripción completa

Detalles Bibliográficos
Autores principales: Betancor, Gilberto, Garriga, César, Puertas, Maria C, Nevot, María, Anta, Lourdes, Blanco, José L, Pérez-Elías, M Jesús, de Mendoza, Carmen, Martínez, Miguel A, Martinez-Picado, Javier, Menéndez-Arias, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468358/
https://www.ncbi.nlm.nih.gov/pubmed/22889300
http://dx.doi.org/10.1186/1742-4690-9-68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468358/
https://www.ncbi.nlm.nih.gov/pubmed/22889300
http://dx.doi.org/10.1186/1742-4690-9-68

Ejemplares similares